NCT01524653View on ClinicalTrials.gov

Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE)

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

July 1, 2016

Study Completion Date

September 1, 2016

Conditions
Venous ThromboembolismDeep Vein ThrombosisNeoplasms
Interventions
DRUG

Rosuvastatin

20 mg po od

DRUG

Placebo

20 mg po od

Trial Locations (1)

05401

Fletcher Allen Health Care, Burlington

All Listed Sponsors
lead

University of Vermont

OTHER

NCT01524653 - Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) | Biotech Hunter | Biotech Hunter